Serum soluble urokinase type plasminogen activated receptor and focal segmental glomerulosclerosis: a systematic review and meta-analysis

OBJECTIVES: Soluble urokinase plasminogen activated receptor (suPAR) is a biomarker that may predict the occurrence of focal segmental glomerulosclerosis (FSGS); however, there is still controversy about whether suPAR can predict FSGS. In this study, we performed a systematic evaluation and meta-ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuai, Tiankui, Pei Jing, Yan, Huang, Qiangru, Xiong, Huaiyu, Liu, Jingjing, Zhu, Lei, Yang, Kehu, Jian, Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Renal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797292/
https://www.ncbi.nlm.nih.gov/pubmed/31594897
http://dx.doi.org/10.1136/bmjopen-2019-031812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797292/
https://www.ncbi.nlm.nih.gov/pubmed/31594897
http://dx.doi.org/10.1136/bmjopen-2019-031812

Ejemplares similares